MedPage Today  May 25  Comment 
(MedPage Today) -- Optimal timing of initiation for RTT still unkown
MarketWatch  Apr 20  Comment 
American Renal Associates Holdings Inc. said Wednesday it priced its initial public offering of 7.5 million shares at $22.00 a share, at the higher end of the expected pricing range of $20 to $23. The provider of dialysis services also granted...
The Times of India  Apr 13  Comment 
MUNICH & AUCKLAND, (BSW) -Diaverum, one of the leading renal care providers worldwide, inaugurated its first dialysis clinic in New Zealand.
MedPage Today  Mar 31  Comment 
(MedPage Today) -- Whose priorities matter most in dialysis decisions?
MedPage Today  Mar 22  Comment 
(MedPage Today) -- Fewer deaths, CV events, and complications observed
Forbes  Mar 14  Comment 
“Dialysis patients receive treatment in a facility for an average of four hours per treatment, three times a week,” according to Dr. Stephen McMurray, VP of Clinical Integrated Care Management at DaVita.
NPR  Mar 8  Comment 
About 5,500 immigrants who entered the U.S. illegally need dialysis. The publicly funded insurance they're eligible to receive only covers the treatment when it's urgently required.
The Hindu Business Line  Mar 3  Comment 
A great idea, quality is key
Benzinga  Mar 2  Comment 
Bernstein’s Lisa Bedell Clive maintained a Market-Perform rating for DaVita HealthCare Partners Inc (NYSE: DVA), while reducing the price target from $74.50 to $71. DaVita reported its Q415 EPS 4 percent ahead of expectations. The...
The Hindu Business Line  Mar 1  Comment 
The budget proposal to launch a National Dialysis Service Programme to provide treatment at all district hospitals through a public-private partnership has been hailed by Azad Moopen, CMD of Aster DM...


Companies in this industry provide dialysis services to patients with diabetes. These companies make a substantial portion of their revenue from prescribing diabetes drugs. They also heavily dependent on Medicare and Medicaid.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki